Blue Trust’s Alaunos Therapeutics TCRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-135
Closed -$305 – 2759
2026
Q2
$305 Hold
135
– – ﹤0.01% 2378
2026
Q1
$386 Hold
135
– – ﹤0.01% 2368
2025
Q4
$436 Hold
135
– – ﹤0.01% 2415
2025
Q3
$325 Buy
+135
New +$385 ﹤0.01% 2475

Other funds holding TCRT

Blue Trust's TCRT Position: Q3 2026 in Review

Blue Trust sold out of Alaunos Therapeutics (TCRT) in Q3 2026, closing a stake of 135 shares — an estimated $305 sold.

Blue Trust first reported a position in TCRT in Q3 2025 and held it in 4 quarters. The position peaked at $436 in Q4 2025. 24 funds tracked by Wall St. Rank hold TCRT as of Q3 2026.

  • Blue Trust reported no remaining Alaunos Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Blue Trust sold 135 Alaunos Therapeutics shares in Q3 2026, an estimated $305.
  • Blue Trust first reported a position in Alaunos Therapeutics in Q3 2025 and held it in 4 quarters.
  • Blue Trust's Alaunos Therapeutics position peaked at $436 in Q4 2025.
  • 24 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q3 2026.

Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.